Analysts See $-0.43 EPS for aTyr Pharma, Inc. (LIFE)

Adrian Erickson

Analysts expect aTyr Pharma, Inc. (NASDAQ:LIFE) to report $-0.43 EPS on March, 15.They anticipate $0.10 EPS change or 18.87 % ...

EPS for Kingstone Companies, Inc. (KINS) Expected At $0.29

Stephen Andrade

Investors sentiment decreased to 1.3 in Q3 2017. Its down 0.99, from 2.29 in 2017Q2. It turned negative, as 5 ...

Analysts See $0.04 EPS for Houston Wire & Cable Company (HWCC)

Darrin Black

Investors sentiment decreased to 0.67 in 2017 Q3. Its down 0.14, from 0.81 in 2017Q2. It dived, as 5 investors ...

EPS for Histogenics Corporation (HSGX) Expected At $-0.22

Vivian Park

Analysts expect Histogenics Corporation (NASDAQ:HSGX) to report $-0.22 EPS on March, 15.They anticipate $1.38 EPS change or 86.25 % from ...

EPS for Fate Therapeutics, Inc. (FATE) Expected At $-0.26

Clifton Ray

Investors sentiment increased to 1.79 in 2017 Q3. Its up 0.36, from 1.43 in 2017Q2. It improved, as 3 investors ...

EPS for Consolidated Water Co. Ltd. (CWCO) Expected At $0.18

Kurt Siggers

Investors sentiment decreased to 1.21 in 2017 Q3. Its down 0.16, from 1.37 in 2017Q2. It turned negative, as 6 ...

ChromaDex Corporation (CDXC) Analysts See $-0.01 EPS

Maria Brooks

Analysts expect ChromaDex Corporation (NASDAQ:CDXC) to report $-0.01 EPS on March, 15.They anticipate $0.05 EPS change or 83.33 % from ...

Analysts See $-0.01 EPS for ChromaDex Corporation (CDXC)

Adrian Erickson

Analysts expect ChromaDex Corporation (NASDAQ:CDXC) to report $-0.01 EPS on March, 15.They anticipate $0.05 EPS change or 83.33 % from ...

« Previous PageNext Page »